Outcomes and Monitoring

Cross-source consensus on Outcomes and Monitoring from 1 sources and 6 claims.

1 sources · 6 claims

Risks & contraindications

Adherence is defined as completing 80% of assigned exercises in at least 10 of 12 weeks. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
Clinical assessments occur at baseline, 12 weeks, and 24 weeks with blinded outcome assessors. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
Everyday activity and sleep are measured with an Actigraph accelerometer after each test day. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
Exercise data are collected weekly from the sports watch and app logs. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
Secondary outcomes include medication use, fitness, strength, sleep, quality of life, work participation, adverse events, and disease activity at week 24. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
Potential adverse events include muscle soreness, fatigue, and symptomatic exacerbations from overexercising. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial